Curi Bio unveils new, larger lab space in Interbay
Curi Bio, a Seattle-based biotech company, has settled into its new 13,942-square-foot space in Interbay.
Founded in 2016, Curi Bio makes stem cell-based tissue models to aid drug discovery, including skeletal muscle models, cardiac models and disease models, along with data analysis tools. “About five years ago, we had a friend show us this building. I remember walking in like, ‘This is gorgeous. We’re never going to get to the level to be here,'” said CEO Nicholas Geisse. “Now we’re here, so it’s kind of a long-term dream.”
The move enhances Curi Bio’s capacity for innovation and strengthens Interbay’s position as a hub for life science companies.